The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2025 | Advances in myeloma therapy from EHA 2025
In this video, Wenming Chen, MD, Beijing Chaoyang Hospital, Beijing, China, discusses key advances in frontline and relapsed multiple myeloma from the EHA 2025 meeting. This video is provided courtesy of TalkMED, in collaboration with Magdalen Medical Publishing (MMP). The interview was recorded at the 30th Congress of the European Hematology Association (EHA) in Milan, Italy.
These works are protected by copyright laws and treaties around the world. All rights are reserved.
